DJIA 16,892.08 -150.82 -0.88%
NASDAQ 4,445.75 -47.64 -1.06%
S&P 500 1,957.91 -14.38 -0.73%
market minute promo

Pfizer (NYSE: PFE)

29.19 -0.38 (-1.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $29.18 -1.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.37
Previous Close $29.57
Daily Range $29.06 - $29.41
52-Week Range $27.87 - $32.96
Market Cap $185.1B
P/E Ratio 18.60
Dividend (Yield) $1.04 (3.5%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 6,959,212
Average Daily Volume 21,446,974
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?

Big pharma dividends are known for being robust, but not all dividends are created equally. Between Johnson & Johnson and Pfizer find out which is the better dividend stock for investors.

Merrill Lynch’s Key Stock Picks for the Fourth Quarter

With Ebola Looming, When Will The Defense Department Get Around To Generex?

GlycoMimetics Down Due to Delay in Rivipansel Study - Analyst Blog

Johnson & Johnson Is The Most Attractive Mega-Cap Pharma Stock For Income Investors

Update: AstraZeneca Moves Closer To EU Approval For Moventig

3 Stocks Reiterated As A Buy: PFE, CELG, BIIB

Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?

Can Pfizer Grow Without A Big Acquisition?

Copycat technology is the next big thing

See More PFE News...

PFE's Top Competitors

PFE $29.19 (-1.29%)
Current stock: PFE
JNJ $104.82 (-1.66%)
Current stock: JNJ
ROG $54.29 (-0.86%)
Current stock: ROG
GSK $45.99 (0.04%)
Current stock: GSK